Close this search box.

BOSS-ME: Biological Outlier and Subtyping Software for ME/CFS

This project will develop a software tool to rapidly look for metabolism anomalies in an individual which might be explained by their genes. It will also look for potentially damaging genes in individuals and it will attempt to group ME/CFS patients based on their genetic and metabolic profiles.

  • Katherine Huang
  • Natalie Thomas, PhD
  • Robert Phair, PhD
  • David Ascher, PhD
  • Paul Gooley, PhD
  • Christopher Armstrong, PhD


  • Method optimisation complete and a systematic review compiling NMR metabolomics workflows employed in the literature has been published (click here).
  • Completed application for UK Biobank data: outcome successful.
  • Currently submitting and writing papers on UKB metabolism data to identify potential biomarkers between ME/CFS and healthy and co-morbidities

This project aims to create a tool that can quickly identify unusual metabolic patterns in individuals that might be linked to their genetic makeup. It will also search for genes that could potentially cause harm. Specifically, the tool will be used to classify patients with ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) based on their genetic and metabolic information.

The tool will be designed using data from over 1,000 people who reported having ME/CFS in the UK Biobank, which holds clinical data and blood samples from more than 300,000 individuals. By comparing these ME/CFS patients with others who have similar illnesses, we have been able to spot unique metabolic patterns that help identify ME/CFS in a person.

This new tool will be especially useful for doctors as it will make diagnosing ME/CFS faster and more accurate by spotting genetic and metabolic issues that might otherwise go unnoticed.


  1. Observe the relationship between genes and metabolism to identify outlier genetic anomalies and pathways in ME/CFS.
  2. Determine the relationship between metabolism and genes in ME/CFS as compared to other similar diseases.
  3. Develop an algorithm to rapidly extract outlier and pattern pathways of disease.
  4. Test and validate algorithm produced on a well-curated set of ME/CFS patients with metabolism and gene data.
  5. Eventually produce software to simplify this process.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.

How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669